Literature DB >> 7644468

Cloning and characterization of a human type II receptor for bone morphogenetic proteins.

B L Rosenzweig1, T Imamura, T Okadome, G N Cox, H Yamashita, P ten Dijke, C H Heldin, K Miyazono.   

Abstract

Bone morphogenetic proteins (BMPs) are members of the transforming growth factor beta superfamily. Several members of this family have been shown to transduce their signals through binding to type I and type II serine-(threonine) kinase receptors. Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to DAF-4, a BMP type II receptor from Caenorhabditis elegans. In transfected COS-1 cells, osteogenic protein (OP)-1/BMP-7, and less efficiently BMP-4, bound to BMPR-II. BMPR-II bound ligands only weakly alone, but the binding was facilitated by the presence of previously identified type I receptors for BMPs. Binding of OP-1/BMP-7 to BMPR-II was also observed in nontransfected cell lines. Moreover, a transcriptional activation signal was transduced by BMPR-II in the presence of type I receptors after stimulation by OP-1/BMP-7.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7644468      PMCID: PMC41199          DOI: 10.1073/pnas.92.17.7632

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.

Authors:  K Tsuchida; L S Mathews; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

2.  Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.

Authors:  R Ebner; R H Chen; L Shum; S Lawler; T F Zioncheck; A Lee; A R Lopez; R Derynck
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

3.  Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.

Authors:  P ten Dijke; H Ichijo; P Franzén; P Schulz; J Saras; H Toyoshima; C H Heldin; K Miyazono
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

4.  Characterization of type I receptors for transforming growth factor-beta and activin.

Authors:  P ten Dijke; H Yamashita; H Ichijo; P Franzén; M Laiho; K Miyazono; C H Heldin
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

Review 5.  Bone and cartilage differentiation.

Authors:  A H Reddi
Journal:  Curr Opin Genet Dev       Date:  1994-10       Impact factor: 5.578

6.  Cloning of a second type of activin receptor and functional characterization in Xenopus embryos.

Authors:  L S Mathews; W W Vale; C R Kintner
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

7.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

Authors:  P ten Dijke; H Yamashita; T K Sampath; A H Reddi; M Estevez; D L Riddle; H Ichijo; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

8.  Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development.

Authors:  L Dale; G Howes; B M Price; J C Smith
Journal:  Development       Date:  1992-06       Impact factor: 6.868

9.  DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction.

Authors:  C M Jones; K M Lyons; P M Lapan; C V Wright; B L Hogan
Journal:  Development       Date:  1992-06       Impact factor: 6.868

10.  Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function.

Authors:  W J Gullick; J Downward; M D Waterfield
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  109 in total

1.  Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression.

Authors:  Mahta Nili; Ujwal Shinde; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  [Injectable carrier system for growth factor application in minimally invasive stimulation of bone healing].

Authors:  H Windhagen; F Witte; F Thorey; C Hurschler; C J Wirth
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

3.  Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling.

Authors:  Anke Hartung; Keren Bitton-Worms; Maya Mouler Rechtman; Valeska Wenzel; Jan H Boergermann; Sylke Hassel; Yoav I Henis; Petra Knaus
Journal:  Mol Cell Biol       Date:  2006-08-21       Impact factor: 4.272

Review 4.  Potential roles of bone morphogenetic proteins (BMPs) in skeletal repair and regeneration.

Authors:  Takanobu Nakase; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.

Authors:  Jonathan W Lowery; Giuseppe Intini; Laura Gamer; Sutada Lotinun; Valerie S Salazar; Satoshi Ote; Karen Cox; Roland Baron; Vicki Rosen
Journal:  J Cell Sci       Date:  2015-02-06       Impact factor: 5.285

6.  Cadherin-6B stimulates an epithelial mesenchymal transition and the delamination of cells from the neural ectoderm via LIMK/cofilin mediated non-canonical BMP receptor signaling.

Authors:  Ki-Sook Park; Barry M Gumbiner
Journal:  Dev Biol       Date:  2012-04-19       Impact factor: 3.582

7.  Expression of bone morphogenetic protein receptor (BMPR) during perinatal ovary development and primordial follicle formation in the hamster: possible regulation by FSH.

Authors:  Cheng Wang; Shyamal K Roy
Journal:  Endocrinology       Date:  2008-12-12       Impact factor: 4.736

8.  A pair of transmembrane receptors essential for the retention and pigmentation of hair.

Authors:  Rong Han; Hideyuki Beppu; Yun-Kyoung Lee; Katia Georgopoulos; Lionel Larue; En Li; Lorin Weiner; Janice L Brissette
Journal:  Genesis       Date:  2012-06-19       Impact factor: 2.487

9.  Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis.

Authors:  A Rebbapragada; H Benchabane; J L Wrana; A J Celeste; L Attisano
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.

Authors:  Ayako Nishihara; Tetsuro Watabe; Takeshi Imamura; Kohei Miyazono
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.